β-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas

Endocrine-Related Cancer

Volumn 17, Issue 1, 2010, Pages 1-6

  Cetani, F ^a   Pardi, E ^a   Banti, C ^a   Collecchi, P ^a   Viacava, P ^a   Borsari, S ^a   Fanelli, G ^a   Naccarato, A G ^a   Saponaro, F ^a   Berti, P ^a   Miccoli, P ^a   Pinchera, A ^a   Marcocci, C ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; EXON; GENE MUTATION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; NUCLEOTIDE SEQUENCE; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; PARATHYROID GLAND; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 77449145777     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0147     Document Type: Article

References (16)

1. Arnold A, Shattuck TM, Mallya SM, Krebs LJ, Costa J, Gallagher J, Wild Y & Saucier K 2002 Molecular pathogenesis of primary hyperparathyroidism. Journal of Bone and Mineral Research 7 N30-N36.
2. Björklund P, Akerström G & Westin G 2007 Accumulation of nonphosphorylated β-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors. Journal of Clinical Endocrinology and Metabolism 92 338-344.
3. Björklund P, Lindberg D, Akerström G & Westin G 2008 Stabilizing mutation of CTNNB1/β-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients. Molecular Cancer 7 53-60.
4. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD et al. 2002 HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumors syndrome. Nature Genetics 32 676-680.
5. Cetani F, Pardi E, Borsari S, Viacava P, Dipollina G, Cianferotti L, Ambrogini E, Gazzerro E, Colussi G, Berti P et al. 2004 Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. Journal of Clinical Endocrinology and Metabolism 89 5583-5591.
6. Costa-Guda J & Arnold A 2007 Absence of stabilizing mutations of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas. Journal of Clinical Endocrinology and Metabolism 92 1564-1566.
7. DeLellis RA, Lloid RV, Heitz PU & Eng C 2006 Pathology and genetics of the tumors of endocrine organs. In WHO Classification of Tumors, pp 124-127. Eds RA DeLellis, RV Lloyd, PU Heitz & C Eng. Lyon: IARC Press.
8. Gamallo C, Palacios J, Moreno G, Calvo de Mora J, Suarez A & Armas A 1999 β-Catenin expression pattern in stage I and II ovarian carcinomas. American Journal of Pathology 155 527-536.
9. Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J et al. 2003 HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. Journal of Medical Genetics 40 657-663.
10. Ikeda S, Ishizaki Y, Shimizu Y, Fujimori M, Ojima Y, Okajima M, Sugino K & Asahara T 2002 Immunohistochemistry of cyclin D1 and β-catenin, and mutational analysis of exon 3 of β-catenin gene in parathyroid adenomas. International Journal of Oncology 20 463-466.
11. Juhlin CC, Haglund F, Villablanca A, Forsberg L, Sandelin K, Bränström R, Larsson C & Höög A 2009 Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-β in parathyroid carcinomas. International Journal of Oncology 34 481-492.
12. Marcocci C, Cetani F, Rubin MR, Silverberg SJ, Pinchera A & Bilezikian JP 2008 Parathyroid carcinoma. Journal of Bone and Mineral Research 23 1869-1880.
13. Mosimann C, Hausmann G & Basler K 2006 Parafibromin/ Hyrax activates Wnt/Wg target gene transcription by direct association with β-catenin/ Armadillo. Cell 125 327-341.
14. Polakis P 2007 The many ways of Wnt in cancer. Current Opinion in Genetics & Development 17 45-51.
15. Semba S, Kusumi R, Moriya T & Sasano H 2000 Nuclear accumulation of B-catenin in human endocrine tumors: association with Ki-67 (MIB-1) proliferative activity. Endocrine Pathology 11 243-250.
16. Shattuck TM, Välimäki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD et al. 2003 Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. New England Journal of Medicine 349 1722-1729.